| Abad-Molina, Maria (AgroSavfe 201402– Head of Product + Business Development before CropDesign) |
Business Development Manager / Strategy Manager |
Biotalys (Group) |
Belgium |
| Abbey, Jeff (Argos Therapeutics 200604 VP Business Development) |
Business Development Manager / Strategy Manager |
Argos Therapeutics (Group) |
United States (USA) |
| Abi-Saab, Walid (Galapagos 201809 CMO) |
Chief Medical Officer (CMO) |
Galapagos (Group) |
Belgium |
| Abraham, Robert (Pfizer 201412 SVP + CSO at Onology Research Unit) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Pfizer (Group) |
United States (USA) |
| Acharya, Anuradha (Ocimum Biosolutions 200408) |
n. a. |
Ficus Enterprises (Group) |
India |
| Adelus, Benoît (Sebia 200802– before Eurofins EVP + bioMérieux CEO + Merial) |
Chief Executive Officer (CEO) |
Sebia (Group) |
France |
| Ahanola, Jani (Noona Healthcare 201611 CEO) |
Chief Executive Officer (CEO) |
Noona Healthcare (FI) |
Finland |
| Ahlberg, Christopher (Spotfire 200505 CEO) |
Chief Executive Officer (CEO) |
TIBCO Software (Group) |
United States (USA) |
| Albert, Winfried (AdnaGen 200810 Managing Director before COO + CSO) |
Managing Director |
Qiagen (Group) |
Germany |
| Aldag, Jörn (Hookipa Biotech 201606– CEO before Uniqure/AMT + Evotec + MAN GHH) |
Chief Executive Officer (CEO) |
Hookipa (Group) |
Austria |
| Alfheim, Jan A. (Oncoinvent 202006 CEO) |
Chief Executive Officer (CEO) |
Oncoinvent AS |
Norway |
| Allaer, Didier (Diagenode 201105 CEO) |
Chief Executive Officer (CEO) |
Hologic (Group) |
Belgium |
| Allan, Eva-Lotta (Immunocore 201305– CBO before Ablynx 200606– CBO before Vertex Pharmaceuticals) |
Chief Business Officer (CBO) |
Immunocore (Group) |
United Kingdom (GB) |
| Allen, Debbie (Argen-X 201204 Senior Director Business Development) |
Business Development Manager / Strategy Manager |
Argenx (Argen-X) (Group) |
Netherlands |
| Allen, Peter (Celltech 1992–2004 CFO) |
Board member, non-executive |
UCB (Group) |
United Kingdom (GB) |
| Alloueche, Ali (Affiris 201112– CBO before GSK Biologicals before Novartis Vaccines and Diagnostics) |
Chief Business Officer (CBO) |
Affiris AG |
Austria |
| Altink, Alexander (Kreatech 2000– CEO before van Ommeren & Ceteco) |
Chief Executive Officer (CEO) |
Danaher (Group) |
Netherlands |
| Amar, Frédéric (Esperite 201801 CEO) |
Chief Executive Officer (CEO) |
Esperite (Group) |
Netherlands |
| Ammon (formerly Alexandru), Anca (Ammon Communications 202103 before MorphoSys + Affimed + MacDougall European Office) |
Public Relations Manager / Investor Relations Manager |
Affimed (Group) |
Germany |
| Anacleto, Joe (Bruker 201312 VP of Market Development before AB SCIEX + Life Technologies) |
Business Development Manager / Strategy Manager |
Bruker (Group) |
United States (USA) |
| Anderson, Steve (LabCorp 201904 CSO at Covance) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
LabCorp (Group) |
United States (USA) |
| Andreou, Ioanna (Qiagen 200705 Senior Scientist RnD) |
n. a. |
Qiagen (Group) |
Germany |
| Andriukaitis, Vytenis (EU (govt) 201801 Commissioner for Health and Food Safety) |
Minister |
EU (govt) |
Belgium |
| Anson, John (Oxford Gene Technology 200601– before Amersham Biosciences/GE Healthcare) |
n. a. |
Sysmex (Group) |
United Kingdom (GB) |
| Antay, Pamela (Eurofins 201609 Head Corp Communication + IR) |
Public Relations Manager / Investor Relations Manager |
Eurofins (Group) |
Luxembourg |
| Antonelli, Michele (UCB 201201– EVP + Managing Director UCB France before Head Technical Operations + Quality) |
Managing Director |
UCB (Group) |
Belgium |
| Antoni, Christian (Sanofi 201502 VP + Head Immunology + Inflammation Franchise RnD) |
President/Director/Head Business Group/Unit/Division |
Sanofi (Group) [since May 2011] |
France |
| Arabian, Bruno (Ulysse Communication 201807 before Milestones 201511) |
Public Relations Manager / Investor Relations Manager |
Ulysse Communication GIE |
France |
| Aranowska-Bablok, Anna (Joint Polish Investment Fund 201503 General Partner) |
General Partner (venture partner) |
Joint Polish Investment Fund (JPIF) (Group) |
Netherlands |
| Archinard, Philippe (Institu Mérieux 202101– EVP Technological Innovation + Scientific Partnerships before Transgene) |
Chief Executive Officer (CEO) |
Mérieux (Group) |
France |
| Arie, Jean-Philippe (Luxembourg (govt) 201803– Manager of BioHealth Cluster before Genopole) |
Cluster Manager |
Luxembourg (govt) |
Luxembourg |
| Arnold, Drew (Cartagenia 201203– VP Sales + BusDev North America before GenomeQuest/Gene-IT + Lion Bioscience) |
Sales Manager / Marketing Manager |
Agilent (Group) |
United States (USA) |
| Arnold, Jonathan (Qiagen 201606 Oncology Franchise Leader) |
Product Manager (personnel) |
Qiagen (Group) |
Netherlands |
| Arnold, Katja (MC Services 201309 CIRO Executive Director before Wilex AG + CAT Consultants) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Ashery, Yoram (NST NeuroSurvival Technologies 200808 CEO) |
Chief Executive Officer (CEO) |
Aposense Ltd. |
Israel |
| Ashton, Chris (Argenta Discovery 200508 CEO) |
Chief Executive Officer (CEO) |
Pulmagen Therapeutics Ltd. |
United Kingdom (GB) |
| Ashton, Mark (Evotec 200910 EVP Business Development) |
Business Development Manager / Strategy Manager |
Evotec (Group) |
Germany |
| Aspinall, Adam (Norgine 201107– Global Marketing Director before Amgen International Marketing Manager in Zug) |
Sales Manager / Marketing Manager |
Norgine (Group) |
Netherlands |
| Astley-Sparke, Philip (Forbion 201209– Venture Partner before Amgen + BioVex CEO since 2005 + JP Morgan) |
Venture Partner |
Forbion Capital Partners (NL) |
Netherlands |
| Atlas, Mark (Fluxion 200804 Director Sales) |
Sales Manager / Marketing Manager |
Fluxion Biosciences Inc. |
United States (USA) |
| Atrzadeh, Faranak (Curetis 201904 SVP Scientific Affairs + Marketing) |
Sales Manager / Marketing Manager |
Curetis (Group) |
Netherlands |
| Autret, Arnaud (Merck (DE) 202002 Investment Principal at M Ventures) |
Principal (venture capital) |
Merck (DE) (Group) |
Netherlands |
| Avery, Jason (Merus 201206– CBO before Affitech Head Bus Dev + Cambridge Antibody Technology CBO) |
Chief Business Officer (CBO) |
Merus (Group) |
Netherlands |
| Avinoam, Sapir (Teva 201608 VP + General Manager of Teva Israel) |
General Manager (management) |
Teva (Group) |
Israel |
| Awada, A. (Institut Jules Bordet 201105 Investigator) |
Researcher (university / research institute) |
Institut Jules Bordet |
Belgium |
| Azzam, Fouad (Life Sciences Partners 201509 Partner at US Office of LSP) |
Partner (venture partner) |
Life Sciences Partners (LSP) |
United States (USA) |
| Bacher, Johannes (Curetis 201804 COO before Managing Director + Co-Founder) |
Chief Operating Officer (COO) |
Curetis (Group) |
Germany |
| Bader, Manuela (Probiodrug 201711 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Vivoryon (Group) |
Germany |
| Baldi, Alessandro (Protea Biosciences 201110– VP + General Manager before own consulting firm before PerkinElmer) |
General Manager (management) |
Protea Biosciences (Group) |
United States (USA) |
| Baldo, Marjolaine (Agendia 201712 Commercial VP EMEA) |
Sales Manager / Marketing Manager |
Agendia (Group) |
Netherlands |
| Balkema, Jurjen (Westburg BV 201307 Commercial Director + Co-owner) |
Chief Commercial Officer (CCO) |
Westburg (Group) |
Netherlands |
| Ballerini, Maurizio (Proteomedix 202006– VP Market Development EMEA before MDxHealth + GenProbe + Stryker + Randox) |
Sales Manager / Marketing Manager |
Proteomedix AG |
Switzerland |
| Balling, Rudolf (Univ Luxembourg 201207 Director of LCSB before GBF 200511) |
President/Director/Head Business Group/Unit/Division |
University of Luxembourg |
Luxembourg |
| Ballmer, Allison (Agilent 202101– SVP Strategy + Corporate Development joined 5/18 before Roche + Biocartis) |
Business Development Manager / Strategy Manager |
Agilent (Group) |
United States (USA) |
| Balthrop, Patrick J. (Apalachee Ventures 201602 Founding Prinicpal before Luminex 200405–2014 CEO) |
Principal (venture capital) |
Apalachee Ventures |
|
| Balusson, Hervé (Olmix 201508 CEO + Founder + Board Director of Biotech France) |
Chief Executive Officer (CEO) |
Olmix (Group) |
France |
| Bancel, Stéphane (Moderna 2011– CEO before bioMérieux 201010 CEO + Eli Lilly) |
Chief Executive Officer (CEO) |
Moderna (Group) |
United States (USA) |
| Bangs, Alex (Entelos 200502) |
n. a. |
Entelos (Group) |
United States (USA) |
| Barberich, Timothy J. (Sepracor 200602 CEO) |
Chief Executive Officer (CEO) |
Dainippon Sumitomo (Group) |
United States (USA) |
| Bardissi, Wafik (Minapharm –200704– CEO) |
Chief Executive Officer (CEO) |
Minapharm (Group) |
Egypt |
| Bardon, Christiana (UBS Oncology Impact Fund 201806 Managing Director) |
Managing Director |
UBS (Group) |
United Kingdom (GB) |
| Barél, Erna (BaseClear 1993– Managing Director + Founder) |
Managing Director |
BaseClear B.V. |
Netherlands |
| Barfod, Lars (Elsevier MDL 200510 CEO) |
Chief Executive Officer (CEO) |
Dassault Systèmes (3DS) (Group) |
United States (USA) |
| Barka, Günes (SunChrom 201003 Managing Director) |
Managing Director |
SunChrom Wissenschaftliche Geräte GmbH |
Germany |
| Barlow, Raymond (Ray) (Kiadis 202007– CBO before e-therapeutics + Amgen + Crucell Vaccines + AstraZeneca) |
Chief Business Officer (CBO) |
Kiadis (Group) |
United Kingdom (GB) |
| Barner, Andreas (Boehringer) |
Board member |
Boehringer Ingelheim (Group) |
Germany |
| Baron, Colin (Qiagen 201606– Senior Director + Head Product Management NGS Life Sciences) |
Product Manager (personnel) |
Qiagen (Group) |
Germany |
| Barratt, Lawrence (Unilever RnD Colworth 200403) |
n. a. |
Unilever (Group) |
United Kingdom (GB) |
| Barrett, Peter (Atlas Venture 2002– Partner before Celera Genomics before Perkin-Elmer Corp) |
Partner (venture partner) |
Atlas Venture (Group) |
United States (USA) |
| Barrett, Robert (Bob) (Applied Biosystems 200702 VP + General Manager Applied Markets Div) |
General Manager (management) |
Thermo Fisher (Group) |
United States (USA) |
| Barron, Hal (GSK 201801– CSO before Alphabet (Calicio) + Roche/Genentech) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
GlaxoSmithKline (GSK) (Group) |
United Kingdom (GB) |
| Bartlema, Gertjan (Vico Therapeutics 202007 CBO) |
Chief Business Officer (CBO) |
Vico Therapeutics B.V. |
Netherlands |
| Bartonícek, Ladislav (PPF Group 201502 Board Member responsible for biotechnology) |
Board member, executive |
PPF Group (Group) |
Netherlands |
| Basstanie, Luc (M.R.B.B. 201701 Senior Investment Manager at AIF) |
Investment Manager |
M.R.B.B. (BE) (Group) |
Belgium |
| Basteleurs, Inge (Biocartis 201301– General Counsel before UCB NV + Bayer BioScience NV) |
General Counsel / Chief Legal Officer (CLO) |
Biocartis (Group) |
Belgium |
| Bastianelli, Enrico (Bone Therapeutics 2006c–201610 CEO RESIGNED 10/16) |
Chief Executive Officer (CEO) |
Bone Therapeutics (Group) |
Belgium |
| Bath, Christopher (Norgine 201705 CFO) |
Chief Financial Officer (CFO) |
Norgine (Group) |
Netherlands |
| Bath, Jennifer L. (ImmunoPrecise 201904 CEO before Aldevron LLC) |
Chief Executive Officer (CEO) |
ImmunoPrecise (Group) |
Canada |
| Bauer, Michael (Cellestia Biotech 201701 CEO) |
Chief Executive Officer (CEO) |
Cellestia Biotech AG |
Switzerland |
| Baum, Binah (Alma Bio Therapeutics 201706 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Alma Bio Therapeutics S.A.S |
France |
| Baynes, David (Biofusion Plc. 200610 CEO) |
Chief Executive Officer (CEO) |
Fusion IP (Group) |
United Kingdom (GB) |
| Beall, Robert J. (Cystic Fibrosis Foundation 200601 CEO) |
Chief Executive Officer (CEO) |
Cystic Fibrosis Foundation |
United States (USA) |
| Béchard, David (Cytune Pharma 201502 President + Founder) |
Chief Executive Officer (CEO) |
Cytune Pharma S.A.S. |
France |
| Bechu, Sophie (Philips 201609– EVP + Chief of Operations before IBM for over 30 years) |
Chief Operating Officer (COO) |
Philips (Group) |
Netherlands |
| Beck, Jürgen (Promethera 201512– VP Clinical + Medical Affairs before Boehringer + Synthélabo + Epigenomics + InterMune) |
Chief Medical Officer (CMO) |
Promethera (Group) |
Belgium |
| Beck, Nico (Spark Holland 201003 OEM Technical Support Specialist) |
Technical Manager |
Spark Holland (Group) |
Netherlands |
| Beck, Thomas R. (Tom) (Fidelity Biosciences 201406 Executive Partner before Dyax + UCB Pharma) |
Partner (venture partner) |
F-Prime Capital Partners (F-Prime Biosciences) |
United States (USA) |
| Becker, Thomas |
n. a. |
Eurofins (Group) |
Germany |
| Bedoret, Denis (Imcyse 202009– CEO before MaSTherCell + Quality Assistance SA + McKinsey & Co) |
Chief Executive Officer (CEO) |
Imcyse S.A. |
Belgium |
| Beerman, Noah D. (Poxel 201505– EVP BusDev + President US before Coronado Biosciences + RXi Pharmaceuticals + Indevus) |
Business Development Manager / Strategy Manager |
Galena BioPharma Inc. |
United States (USA) |
| Beijersbergen van Henegouwen, Hans (Isogen Life Science 200611) |
n. a. |
Isogen Life Science (NL) |
Netherlands |
| Beils, Fernando (Siemens 201712 Head of Molecular Diagnostics at Siemens Healthineers) |
President/Director/Head Business Group/Unit/Division |
Siemens (Group) |
Germany |
| Beirnaert, Els (Aelin Therapeutics 202010 CEO before Ablynx + VIB) |
Chief Executive Officer (CEO) |
Aelin Therapeutics (BE) |
Belgium |
| Belawat, Priyanka (HBM 201806 Investment Advisor at HBM Partners) |
Consultant (economic/technology) |
HBM (Group) |
Switzerland |
| Bélingard, Jean-Luc (Mérieux 201101– Président Directeur Général before Ipsen CEO + Pierre Fabre + Roche Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Mérieux (Group) |
France |
| Belissa-Mathiot, Patricia (Servier 201307 Director of Rheumatology Innovative Pole) |
Research & Development Manager |
Servier (Group) |
France |
| Belldegrun, Arie (Allogene 201806 Executive Chairman before Kite Pharma CEO) |
Board member, executive |
Gilead Sciences (Group) |
United States (USA) |
| Ben Har, Limor (Prilenia 202006 COO) |
Chief Operating Officer (COO) |
Prilenia (Group) |
Israel |
| Bender, Richard A. (Agendia 200804– VP + CMO before Spectrum Pharma) |
Chief Medical Officer (CMO) |
Agendia (Group) |
Netherlands |
| Benefiel, Monty (Agilent 201506 Division General Manager Mass Spec before 201302 VP for gas phase systems) |
President/Director/Head Business Group/Unit/Division |
Agilent (Group) |
United States (USA) |
![[LSBNL] Life-Sciences-Benelux.com - The Benelux Life Sciences Web Portal](/images/basics/lsbnl-life-sciences-benelux-portal-logo-2019.png){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
